| ERT | esophageal radionuclide transit; estrogen replacement therapy; examination room terminal; external r... |
|---|---|
| ICT | icteric, icterus; indirect Coombs test; inflammation of connective tissue; insulin coma therapy; int... |
| OT | objective test; oblique talus; occlusion time; occupational therapist, occupational therapy; ocular ... |
| PT | pain threshold; parathormone; parathyroid; paroxysmal tachycardia; part time; patient; pericardial t... |
| ASDC | Association of Sleep Disorders Centers; 미국 수면 질환 센터 협회 |
| sleep phase delay syndrome | <syndrome> A disorder in which the circadian rhythm of sleep and waking falls into a delayed but stable relationship with external time cues of day and night. (05 Mar 2000) |
|---|---|
| sleep, rem | A stage of sleep characterised by rapid movements of the eye and low voltage fast pattern eeg. It is usually associated with dreaming. (12 Dec 1998) |
| sleep spindle | The electroencephalographic record of 14-per-second bursts of wave frequency seen on EEG examination. (05 Mar 2000) |
| sleep stages | Periods of sleep manifested by changes in eeg activity and certain behavioural correlates; includes stage 1: sleep onset, drowsy sleep; stage 2: light sleep; stages 3 and 4: delta sleep, light sleep, deep sleep, telencephalic sleep. (12 Dec 1998) |
| sleep terror | A disorder allied to nightmare, occurring in children, in which the child awakes screaming with fright, the distress persisting for a time during a state of saemiconsciousness. Synonym: pavor nocturnus, sleep terror. (05 Mar 2000) |
| delta sleep-inducing peptide | <chemical> A nonapeptide that is found in neurons, peripheral organs, and plasma. This neuropeptide induces mainly delta sleep in mammals. In addition to sleep, the peptide has been observed to affect electrophysiological activity, neurotransmitter levels in the brain, circadian and locomotor patterns, hormonal levels, psychological performance, and the activity of neuropharmacological drugs including their withdrawal. Chemical name: Delta sleep-inducing peptide (12 Dec 1998) |
| obstructive sleep apnoea | A form of sleep apnoea which occurs as the result of a physical occlusion of the oropharyngeal airway during sleep. (27 Sep 1997) |
| electric sleep | A condition of convulsions and unconsciousness induced by the passage of an electric current through the brain. (05 Mar 2000) |
| twilight sleep | Formerly a method of producing sleep for delivery by a combination of morphine and scopolamine. (05 Mar 2000) |
| light sleep | A condition of half sleep. Synonym: light sleep. Origin: dys-+ G. Nystaxis, drowsiness (05 Mar 2000) |
| acupuncture therapy | Treatment of disease by inserting needles along specific pathways or meridians. The placement varies with the disease being treated. Heat or moxibustion and acupressure may be used in conjunction. (12 Dec 1998) |
| adjuvant therapy | <oncology, pharmacology> Treatment that is added to increase the effectiveness of a primary treatment. In cancer, adjuvant treatment usually refers to chemotherapy, hormonal therapy or radiation therapy after surgery to increase the likelihood of killing all cancer cells. (14 May 1997) |
| alternative therapy | A term given to nonconventional therapy usually given by persons who do not have a medical qualification. (16 Dec 1997) |
| analytic therapy | Short term for psychoanalytic therapy. (05 Mar 2000) |
| Antibody Directed Enzyme Prodrug Therapy | <pharmacology> A method for targeting a drug to a specific tissue, in which the targeting agent and the drug are administered separately. The drug is designed to be inactive (a prodrug) until it is converted by an enzyme, which is the targeting agent. The enzyme is coupled to an antibody that directs it to the tissue of interest. When the enzyme arrives at the tissue, the prodrug is activated only at that site, sparing other tissues from potentially toxic side effects. Acronym: ADEPT (14 Nov 1997) |